Autologous DC and NK Cells
/ First Hospital of China Medical University
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 18, 2022
Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma
(clinicaltrials.gov)
- P2 | N=1 | Not yet recruiting | Sponsor: China Medical University, China
New P2 trial • Gastrointestinal Cancer • Gastrointestinal Disorder • Oncology
1 to 1
Of
1
Go to page
1